Table of Contents Author Guidelines Submit a Manuscript
Research Article
International Journal of Endocrinology
Volume 2018, Article ID 3029602, 1 page
https://doi.org/10.1155/2018/3029602
Corrigendum

Corrigendum to “Beta-Arrestin 1 Mediates Liver Thyrotropin Regulation of Cholesterol Conversion Metabolism via the Akt-Dependent Pathway”

1Shandong Key Laboratory of Endocrinology and Lipid Metabolism, Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China
2Department of Endocrinology, Lin Yi People’s Hospital Affiliated to Shandong University, Linyi, Shandong 276003, China
3Medical College, Shandong University, Jinan, Shandong 250012, China
4Scientific Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China
5Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China

Correspondence should be addressed to Tao Bo; moc.621@666666oatob

Received 19 August 2018; Accepted 27 August 2018; Published 10 September 2018

Copyright © 2018 Shaona Niu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


In the article titled “Beta-Arrestin 1 Mediates Liver Thyrotropin Regulation of Cholesterol Conversion Metabolism via the Akt-Dependent Pathway” [1], the first affiliation was incomplete. The correct affiliation is shown above.

References

  1. S. Niu, H. Li, W. Chen, J. Zhao, L. Gao, and T. Bo, “Beta-arrestin 1 mediates liver thyrotropin regulation of cholesterol conversion metabolism via the Akt-dependent pathway,” International Journal of Endocrinology, vol. 2018, Article ID 4371396, 12 pages, 2018. View at Publisher · View at Google Scholar